Home | Business News | Browse by Publication | F | FDA Consumer

Novel medicine to prevent fungal infections.

Publication: FDA Consumer
Publication Date: 01-NOV-06
Format: Online
Delivery: Immediate Online Access
Full Article Title: Novel medicine to prevent fungal infections.(Updates)

Article Excerpt
Noxafil (posaconazole) has been approved to prevent fungal infections caused by certain molds and yeast-like fungus called Aspergillus and Candida. The FDA approved the drug in September for use in people who have weakened immune systems after bone marrow transplants and for people with decreased white blood cell counts...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from FDA Consumer
Generic ciprofloxacin injection.(Updates), November 01, 2006
Hepatitis B tests improve safety of donor blood, tissue, and organs.(U..., November 01, 2006
Additional flu vaccine.(Updates), November 01, 2006
The FDA approves new leukemia drug; expands use of current drug.(Updat..., November 01, 2006
New use for Plavix.(Updates), November 01, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.